
CBT
Cabot Corp
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
60.460
Open
60.230
VWAP
59.43
Vol
520.62K
Mkt Cap
3.14B
Low
58.990
Amount
30.94M
EV/EBITDA(TTM)
5.49
Total Shares
55.26M
EV
4.31B
EV/OCF(TTM)
6.64
P/S(TTM)
0.87
Cabot Corporation is a global specialty chemicals and performance materials company. The Company's principal products are reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants and aerogel. It operates through two segments: Reinforcement Materials and Performance Chemicals. Its reinforcing carbon products are used in tires and industrial products. In addition to its reinforcing carbons, it manufactures engineered elastomer composites (E2C) solutions that are composites of reinforcing carbons and rubber made using its patented elastomer composites manufacturing process. Under Performance Chemicals segment, it designs, manufactures and sells materials that deliver performance in a range of customer applications across the automotive, construction, infrastructure, inkjet printing, electronics, and consumer products sectors and in applications related to the generation, transmission and storage of energy.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q2
FY2026Q1
900.30M
-2.46%
1.676
-11.78%
929.03M
-0.74%
1.689
-11.11%
916.69M
-4.01%
1.476
-16.12%
Estimates Revision
The market is revising Downward the revenue expectations for Cabot Corporation (CBT) for FY2025, with the revenue forecasts being adjusted by -0.74% over the past three months. During the same period, the stock price has changed by -23.78%.
Revenue Estimates for FY2025
Revise Downward

-0.74%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-0.58%
In Past 3 Month
Stock Price
Go Down

-23.78%
In Past 3 Month
3 Analyst Rating
Wall Street analysts forecast CBT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBT is 81.67 USD with a low forecast of 75.00 USD and a high forecast of 88.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
1 Sell
Hold
Current: 59.330
Low
75.00
Averages
81.67
High
88.00
Current: 59.330
Low
75.00
Averages
81.67
High
88.00
UBS
Joshua Spector
Neutral
downgrade
$82 -> $65
2025-11-05
New
Reason
UBS
Joshua Spector
Price Target
$82 -> $65
2025-11-05
New
downgrade
Neutral
Reason
UBS analyst Joshua Spector lowered the firm's price target on Cabot to $65 from $82 and keeps a Neutral rating on the shares.
UBS
Joshua Spector
Neutral
maintain
$81 -> $82
2025-08-05
Reason
UBS
Joshua Spector
Price Target
$81 -> $82
2025-08-05
maintain
Neutral
Reason
UBS analyst Joshua Spector raised the firm's price target on Cabot to $82 from $81 and keeps a Neutral rating on the shares.
Deutsche Bank
Hold
downgrade
$95 -> $80
2025-05-27
Reason
Deutsche Bank
Price Target
$95 -> $80
2025-05-27
downgrade
Hold
Reason
Deutsche Bank lowered the firm's price target on Cabot to $80 from $95 and keeps a Hold rating on the shares.
UBS
Joshua Spector
Hold
Maintains
$93 → $83
2025-04-07
Reason
UBS
Joshua Spector
Price Target
$93 → $83
2025-04-07
Maintains
Hold
Reason
JP Morgan
Jeffrey Zekauskas
Sell
Maintains
$105 → $85
2025-02-21
Reason
JP Morgan
Jeffrey Zekauskas
Price Target
$105 → $85
2025-02-21
Maintains
Sell
Reason
Mizuho
John Roberts
Buy
Maintains
$122 → $110
2025-01-07
Reason
Mizuho
John Roberts
Price Target
$122 → $110
2025-01-07
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Cabot Corp (CBT.N) is 8.72, compared to its 5-year average forward P/E of 11.26. For a more detailed relative valuation and DCF analysis to assess Cabot Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued
5Y Average PE
11.26
Current PE
8.72
Overvalued PE
12.81
Undervalued PE
9.70
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
6.94
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
7.61
Undervalued EV/EBITDA
6.27
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
1.44
Current PS
60.47
Overvalued PS
6.72
Undervalued PS
-3.85
Financials
Annual
Quarterly
FY2025Q3
YoY :
-9.15%
923.00M
Total Revenue
FY2025Q3
YoY :
-2.91%
167.00M
Operating Profit
FY2025Q3
YoY :
-5.08%
112.00M
Net Income after Tax
FY2025Q3
YoY :
-4.12%
1.86
EPS - Diluted
FY2025Q3
YoY :
+21.29%
188.00M
Free Cash Flow
FY2025Q3
YoY :
+4.92%
26.44
Gross Profit Margin - %
FY2025Q3
YoY :
-9.52%
9.12
FCF Margin - %
FY2025Q3
YoY :
+3.64%
12.24
Net Margin - %
FY2025Q3
YoY :
-20.30%
17.55
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
9.1M
USD
1
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
29.6K
Volume
1
0-12
Months
156.2K
Volume
1
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
9.1M
USD
1
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CBT News & Events
Events Timeline
2025-11-03 (ET)
2025-11-03
16:44:22
Cabot projects FY26 adjusted EPS between $6 and $7, while consensus estimates at $7.26.
2025-11-03
16:41:25
Cabot announces Q4 adjusted EPS of $1.70, surpassing consensus estimate of $1.68
2025-10-07 (ET)
2025-10-07
09:13:03
Cabot Boosts Production Capabilities for Circular Reinforcing Carbons
Sign Up For More Events
Sign Up For More Events
News
6.0
11-05BenzingaUBS Keeps Neutral Rating on Cabot, Reduces Price Target to $65
8.0
11-05NASDAQ.COMCBT Surpasses 3% Yield Threshold
3.0
11-04NASDAQ.COMCabot Corp to Hold Q4 2025 Earnings Conference Call at 8:00 AM ET
Sign Up For More News
People Also Watch

BCC
Boise Cascade Co
70.730
USD
-0.91%

OPCH
Option Care Health Inc
27.040
USD
-0.15%

IONS
Ionis Pharmaceuticals Inc
74.100
USD
-0.78%

LOPE
Grand Canyon Education Inc
167.050
USD
-6.30%

SM
SM Energy Co
17.910
USD
+0.34%

GEO
Geo Group Inc
15.410
USD
-8.33%

BOOT
Boot Barn Holdings Inc
182.800
USD
-2.41%

TENB
Tenable Holdings Inc
27.380
USD
-1.01%

RRR
Red Rock Resorts Inc
55.230
USD
+1.47%

RDN
Radian Group Inc
33.900
USD
-0.32%
FAQ
What is Cabot Corp (CBT) stock price today?
The current price of CBT is 59.33 USD — it has decreased -1.89 % in the last trading day.





